ProQR Therapeutics BV (PRQR) — Cash Flow Reinvestment Rate

Latest as of March 2023: 0.01x

ProQR Therapeutics BV (PRQR) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $225.00K (capex $136.00K plus investments $-89.00K) from operating cash flow of $44.73 Million. Explore PRQR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$225.00K
Capex + Investments

Operating Cash Flow

$44.73 Million
USD

Capital Expenditures

$136.00K
USD

ProQR Therapeutics BV Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for ProQR Therapeutics BV across 1 annual periods. Also explore ProQR Therapeutics BV (PRQR) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for ProQR Therapeutics BV (2023–2023)

Year-by-year capital reinvestment analysis for ProQR Therapeutics BV. For live market cap and broader valuation context, see ProQR Therapeutics BV market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 0.26x $5.65 Million $21.55 Million $1.37 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow